---
figid: PMC11035064__gr3
pmcid: PMC11035064
image_filename: gr3.jpg
figure_link: /pmc/articles/PMC11035064/figure/fig3/
number: Fig.Â 3
figure_title: ''
caption: 'The metabolism and spatial signatures of wedelolactone (WEL) and demethylwedelolactone
  (DWEL) in zebrafish. (A) Metabolism pathway of WEL and the structural inferences
  of its metabolites. (B) Mass spectrometry (MS) images depicting the spatial distribution
  of WEL and its metabolites in zebrafish whole-body section. (C) Metabolism pathway
  of DWEL and the structural inferences of its metabolites. (D) MS images depicting
  the spatial distribution of DWEL and its metabolites in zebrafish. WEL-Sulf: sulfated
  wedelolactone; WEL-GlcA: glucuronidated wedelolactone; WEL-Sulf-GlcA: sulfated-glucuronidated
  wedelolactone; WEL-Sulf-Glc: sulfated-glucosidated wedelolactone; DWEL-Sulf: sulfated
  demethylwedelolactone; DWEL-GlcA: glucuronidated demethylwedelolactone; DWEL-Sulf-GlcA:
  sulfated-glucuronidated demethylwedelolactone; DWEL-Sulf-Glc: sulfated-glucosidated
  demethylwedelolactone; MWEL: methylated wedelolactone; MWEL-Sulf: methylated and
  sulfated wedelolactone; MWEL-GlcA: methylated and glucuronidated wedelolactone;
  MWEL-Sulf-GlcA: methylated, sulfated and glucuronidated wedelolactone; MWEL-Sulf-Glc:
  methylated, sulfated and glucosidated wedelolactone.'
article_title: Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection
  mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver
  disease.
citation: Panpan Chen, et al. J Pharm Anal. 2024 Apr;14(4):100910.
year: '2024'

doi: 10.1016/j.jpha.2023.11.017
journal_title: Journal of Pharmaceutical Analysis
journal_nlm_ta: J Pharm Anal
publisher_name: Xi'an Jiaotong University

keywords:
- Spatial metabolomics
- Transcriptomics
- Non-alcoholic fatty liver disease
- Wedelolactone
- Demethylwedelolactone

---
